Determining whether one or more of these mechanisms underlie VAT- and FA-induced impairment of Kir2.1 represents a significant step forward in revealing suitable targets to prevent Kir2.1 impairment and, therefore, endothelial dysfunction in obesity. Here, KCNJ2 is linked to endothelial dysfunction.